Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

33.3K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.3K
Signs of Puberty01:27

Signs of Puberty

419
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
419
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

492
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
492
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

742
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
742
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

438
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
438
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

568
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
568

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical Care of Transgender Athletes and Policy Implications: ACSM Contemporary Issue Statement - Erratum.

Medicine and science in sports and exercise·2026
Same author

Medical Care of Transgender Athletes and Policy Implications: ACSM Contemporary Issue Statement.

Medicine and science in sports and exercise·2026
Same author

Care of Diverse Families: Foster Care and Adoption.

FP essentials·2023
Same author

Consistency and applicability of return to function guidelines in tactical-athletes with exertional heat illness. A systematic review.

The Physician and sportsmedicine·2022
Same author

Diagnostic Uncertainty in Cervical Radiculopathy.

Military medicine·2022
Same author

Clinical Considerations in Caring for Transgender Athletes.

American family physician·2021

Related Experiment Video

Updated: Jul 18, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

788

Hormone Therapy: Gender-Affirming Hormone Therapy.

Janelle Marra1

  • 1Department of Family Medicine - Edward Hébert School of Medicine at the Uniformed Services University, 4301 Jones Bridge Rd, Bethesda, MD 20814.

FP Essentials
|August 21, 2023
PubMed
Summary

Gender-affirming hormone therapy is available for transgender and gender-diverse individuals, with specific criteria for adolescents and adults. This care includes puberty blockers, hormone therapy, and regular monitoring for safety and effectiveness.

More Related Videos

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

1.3K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K

Related Experiment Videos

Last Updated: Jul 18, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

788
Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

1.3K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K

Area of Science:

  • Endocrinology
  • Psychiatry
  • Public Health

Background:

  • 0.6% of US adults and 2% of high schoolers identify as transgender or gender diverse.
  • Gender-affirming care encompasses social, legal, and medical interventions, including hormone therapy.
  • Criteria for hormone therapy include persistent gender dysphoria/incongruence and legal consent capacity.

Purpose of the Study:

  • To outline the criteria and phases of gender-affirming hormone therapy for adolescent and adult patients.
  • To detail the medical treatments involved in feminizing and masculinizing hormone therapy.
  • To emphasize the importance of thorough evaluation, risk assessment, and regular monitoring for patients undergoing hormone therapy.

Main Methods:

  • Review of established criteria for initiating gender-affirming hormone therapy.
  • Description of phased treatment approaches for adolescents (pubertal suppression, hormone therapy).
  • Outline of hormone therapy components (estrogen, antiandrogen, testosterone) and risk assessment for adults.

Main Results:

  • Adolescent therapy involves pubertal suppression followed by feminizing or masculinizing hormones, typically initiated at age 16.
  • Adult therapy requires comprehensive evaluation for contraindications and risk factors.
  • Ongoing monitoring, including cancer screening based on individual risk, is crucial for all patients.

Conclusions:

  • Gender-affirming hormone therapy is a critical component of care for transgender and gender-diverse individuals.
  • Adherence to established criteria and phased treatment protocols ensures safe and effective care.
  • Regular monitoring and risk-based screening are essential for long-term patient well-being.